Temsirolimus combined with sorafenib in hepatocellular carcinoma: A phase I dose-finding trial with pharmacokinetic and biomarker correlates

R. K. Kelley Dr., H. S. Nimeiri, P. N. Munster, M. T. Vergo, Y. Huang, C. M. Li, J. Hwang, M. F. Mulcahy, B. M. Yeh, P. Kuhn, M. S. Luttgen, J. A. Grabowsky, L. Stucky-Marshall, W. M. Korn, A. H. Ko, E. K. Bergsland, A. B. Benson, A. P. Venook

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Temsirolimus combined with sorafenib in hepatocellular carcinoma: A phase I dose-finding trial with pharmacokinetic and biomarker correlates'. Together they form a unique fingerprint.

Medicine & Life Sciences